Reckitt Maintains Annual Targets as European Revenue Declines
This article is for subscribers only.
Reckitt Benckiser Group Plc, which last week agreed to buy the maker of Durex condoms, maintained its target for annual profit after reporting a decline in sales in Europe, its largest market.
Revenue in Europe, which accounts for 43 percent of sales, fell 1 percent in the first half, Slough, England-based Reckitt said today. The maker of Nurofen painkillers expects sales growth of 5 percent this year and a 10 percent rise in operating profit, excluding its pharmaceutical unit.